Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 043 660.7 |
96 | EP file number | EAKZ | 06 12 5649.1 |
97 | EP publication number | EPN | 1797892 |
54 | Designation/title | TI | Verwendung von modifizierten Cyclosporinen zur Behandlung von HCV Krankheiten |
51 | IPC main class | ICM (ICMV) | A61K 38/13 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 31/14 (2006.01), A61K 45/06 (2006.01) |
22 | DE application date | DAT | Sep 2, 2004 |
96 | EP application date | EAT | Sep 2, 2004 |
43 | Date of first publication | OT | Jun 20, 2007 |
| Date of publication of grant | PET | Oct 23, 2013 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH |
72 | Inventor | IN | Watashi, Koichi, Ichijo-dori,Kamigyo-ku,Kyoto, 602-0925, JP; Hijikata, Makoto, Kyoto 612-0031, JP; Shimotohno, Kunitada, Kyoto 612-8104, JP |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0320638 Sep 3, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001797892 Searchable text:
EP000001797892 Original document:
EP000001797892B1 Searchable text:
EP000001797892B1 |
43 | Date of first publication | EVT | Jun 20, 2007 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 21, 2018 (Show all update days)(Hide all update days)- Mar 21, 2018; Dec 16, 2015; Jun 25, 2015; May 19, 2015; May 6, 2015; Nov 6, 2014; Oct 2, 2014; May 28, 2014; Dec 24, 2013; Nov 5, 2013; Oct 24, 2013; Jan 30, 2013; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|